Some of us remember radio stations playing two songs from the same artist or band, back to back, with the alliterative “Two for Tuesday” slogan. The Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) played disc jockey on September 22, 2020, and issued two Warning Letters for unlawful drug promotion1, with FDA expressing many similar concerns in both. OPDP has picked up the pace recently with the issuance of letters, and we have described these previously in other AGG Bulletins. And the beat goes on.
We will summarize some of the key points and emphasize what we think are the more relevant takeaways.
 The Warning Letters can be accessed at: www.fda.gov/media/142585/download and www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/currax-pharmaceuticals-llc-610942-09222020